Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (321-330 of 360) with videos related to

Pageof 36
Sort By:
Journal of Diabetes Investigation|September 30, 2022
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetesEiji Kawasaki, Akira Shimada, Akihisa Imagawa, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 16, 2011
Japanese clinical guidelines for chronic pain in children and adolescentsYuko Ishizaki, Hidehiro Yasujima, Yoshito Takenaka, et al.
Journal of Diabetes Investigation|January 24, 2023
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetesEiji Kawasaki, Akira Shimada, Akihisa Imagawa, et al.
Genes, Chromosomes & Cancer|January 8, 2017
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndromeYusuke Hara, Norio Shiba, Kentaro Ohki, et al.
International Journal of Hematology|January 29, 2019
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemiaIkuya Usami, Toshihiko Imamura, Yoshihiro Takahashi, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 4, 2017
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemiaHideki Nakayama, Daisuke Tomizawa, Shiro Tanaka, et al.
Ejhaem|July 18, 2022
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide surveyHisashi Ishida, Yuji Miyajima, Nobuyuki Hyakuna, et al.
International Journal of Hematology|June 26, 2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocolHideki Nakayama, Ken Tabuchi, Akio Tawa, et al.
Blood|August 24, 2010
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemiaRika Kanezaki, Tsutomu Toki, Kiminori Terui, et al.
British Journal of Haematology|April 28, 2020
Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakahiro Aoki, Hiroyuki Takahashi, Shiro Tanaka, et al.
Pageof 36

Showing results (321-330 of 360) with videos related to

Sort By:
Pageof 36
Journal of Diabetes Investigation|September 30, 2022
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetesEiji Kawasaki, Akira Shimada, Akihisa Imagawa, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 16, 2011
Japanese clinical guidelines for chronic pain in children and adolescentsYuko Ishizaki, Hidehiro Yasujima, Yoshito Takenaka, et al.
Journal of Diabetes Investigation|January 24, 2023
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetesEiji Kawasaki, Akira Shimada, Akihisa Imagawa, et al.
Genes, Chromosomes & Cancer|January 8, 2017
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndromeYusuke Hara, Norio Shiba, Kentaro Ohki, et al.
International Journal of Hematology|January 29, 2019
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemiaIkuya Usami, Toshihiko Imamura, Yoshihiro Takahashi, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 4, 2017
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemiaHideki Nakayama, Daisuke Tomizawa, Shiro Tanaka, et al.
Ejhaem|July 18, 2022
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide surveyHisashi Ishida, Yuji Miyajima, Nobuyuki Hyakuna, et al.
International Journal of Hematology|June 26, 2014
Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocolHideki Nakayama, Ken Tabuchi, Akio Tawa, et al.
Blood|August 24, 2010
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemiaRika Kanezaki, Tsutomu Toki, Kiminori Terui, et al.
British Journal of Haematology|April 28, 2020
Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakahiro Aoki, Hiroyuki Takahashi, Shiro Tanaka, et al.
Pageof 36